Cognition Historical Balance Sheet

CGTX Stock

USD 0.45 0.01 2.27%

Trend analysis of Cognition Therapeutics balance sheet accounts such as Short Long Term Debt Total of 508.2 K, Other Current Liabilities of 8.3 M or Total Current Liabilities of 8 M provides information on Cognition Therapeutics' total assets, liabilities, and equity, which is the actual value of Cognition Therapeutics to its prevalent stockholders. By breaking down trends over time using Cognition Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Cognition Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cognition Therapeutics is a good buy for the upcoming year.

Cognition Therapeutics Inventory

2.41 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.

About Cognition Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cognition Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Cognition Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cognition Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cognition currently owns. An asset can also be divided into two categories, current and non-current.

Cognition Therapeutics Balance Sheet Chart

At this time, Cognition Therapeutics' Inventory is fairly stable compared to the past year. Net Invested Capital is likely to rise to about 20 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 508.2 K in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Cognition Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cognition Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cognition Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cognition Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Cognition Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cognition Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.At this time, Cognition Therapeutics' Inventory is fairly stable compared to the past year. Net Invested Capital is likely to rise to about 20 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 508.2 K in 2025.

	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.2M	535K	508.3K
Total Assets	35.2M	30.2M	34.7M

Short Long Term Debt Total Total Assets

Cognition Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.82	0.69	0.81	0.98	0.77	0.94	0.56	0.01	-1.0	-0.7	0.84	1.0	0.59	0.78	1.0	-0.53	0.54	-0.92	0.67	0.9	0.63	0.81	-0.94	0.98	0.68
Short Long Term Debt Total	-0.82		-0.77	-0.89	-0.9	-0.56	-0.92	-0.68	-0.33	0.85	0.82	-0.67	-0.8	-0.54	-0.55	-0.8	0.29	-0.73	0.93	-0.73	-0.85	-0.66	-0.86	0.93	-0.88	-0.77
Other Current Liab	0.69	-0.77		0.88	0.79	0.8	0.88	0.56	-0.04	-0.71	-0.97	0.41	0.7	0.36	0.78	0.7	-0.67	0.87	-0.87	0.66	0.92	0.68	0.85	-0.85	0.79	0.74
Total Current Liabilities	0.81	-0.89	0.88		0.91	0.84	0.95	0.74	0.13	-0.84	-0.94	0.57	0.81	0.5	0.84	0.81	-0.62	0.89	-0.96	0.82	0.94	0.84	0.98	-0.95	0.9	0.88
Total Stockholder Equity	0.98	-0.9	0.79	0.91		0.81	0.99	0.66	0.09	-0.99	-0.82	0.79	0.97	0.6	0.81	0.97	-0.56	0.68	-0.98	0.76	0.95	0.73	0.9	-0.99	1.0	0.78
Other Liab	0.77	-0.56	0.8	0.84	0.81		0.82	0.58	-0.22	-0.77	-0.82	0.44	0.79	0.47	1.0	0.79	-0.82	0.75	-0.81	0.71	0.89	0.76	0.86	-0.8	0.82	0.75
Net Tangible Assets	0.94	-0.92	0.88	0.95	0.99	0.82		0.69	0.11	-0.95	-0.9	0.73	0.93	0.57	0.82	0.93	-0.6	0.77	-1.0	0.78	0.98	0.76	0.94	-1.0	0.98	0.82
Property Plant And Equipment Net	0.56	-0.68	0.56	0.74	0.66	0.58	0.69		0.66	-0.56	-0.73	0.37	0.53	0.87	0.58	0.53	-0.34	0.74	-0.73	0.98	0.69	0.95	0.83	-0.71	0.66	0.96
Current Deferred Revenue	0.01	-0.33	-0.04	0.13	0.09	-0.22	0.11	0.66		0.0	-0.14	0.14	-0.04	0.57	-0.22	-0.04	0.29	0.17	-0.17	0.52	0.05	0.45	0.21	-0.15	0.07	0.46
Net Debt	-1.0	0.85	-0.71	-0.84	-0.99	-0.77	-0.95	-0.56	0.0		0.72	-0.84	-1.0	-0.55	-0.77	-1.0	0.53	-0.56	0.93	-0.66	-0.9	-0.62	-0.83	0.95	-0.99	-0.68
Retained Earnings	-0.7	0.82	-0.97	-0.94	-0.82	-0.82	-0.9	-0.73	-0.14	0.72		-0.42	-0.7	-0.5	-0.8	-0.7	0.65	-0.93	0.91	-0.81	-0.94	-0.83	-0.93	0.89	-0.81	-0.88
Accounts Payable	0.84	-0.67	0.41	0.57	0.79	0.44	0.73	0.37	0.14	-0.84	-0.42		0.85	0.36	0.46	0.85	-0.46	0.15	-0.71	0.43	0.65	0.43	0.52	-0.74	0.79	0.43
Cash	1.0	-0.8	0.7	0.81	0.97	0.79	0.93	0.53	-0.04	-1.0	-0.7	0.85		0.54	0.79	1.0	-0.57	0.52	-0.91	0.64	0.9	0.61	0.8	-0.93	0.98	0.65
Non Current Assets Total	0.59	-0.54	0.36	0.5	0.6	0.47	0.57	0.87	0.57	-0.55	-0.5	0.36	0.54		0.47	0.54	-0.13	0.5	-0.6	0.86	0.57	0.74	0.65	-0.59	0.6	0.79
Long Term Debt	0.78	-0.55	0.78	0.84	0.81	1.0	0.82	0.58	-0.22	-0.77	-0.8	0.46	0.79	0.47		0.79	-0.82	0.74	-0.8	0.71	0.88	0.76	0.85	-0.8	0.82	0.75
Cash And Short Term Investments	1.0	-0.8	0.7	0.81	0.97	0.79	0.93	0.53	-0.04	-1.0	-0.7	0.85	1.0	0.54	0.79		-0.57	0.52	-0.91	0.64	0.9	0.61	0.8	-0.93	0.98	0.65
Net Receivables	-0.53	0.29	-0.67	-0.62	-0.56	-0.82	-0.6	-0.34	0.29	0.53	0.65	-0.46	-0.57	-0.13	-0.82	-0.57		-0.46	0.58	-0.44	-0.7	-0.6	-0.58	0.57	-0.58	-0.51
Common Stock Shares Outstanding	0.54	-0.73	0.87	0.89	0.68	0.75	0.77	0.74	0.17	-0.56	-0.93	0.15	0.52	0.5	0.74	0.52	-0.46		-0.79	0.81	0.81	0.8	0.9	-0.76	0.67	0.87
Non Current Liabilities Total	-0.92	0.93	-0.87	-0.96	-0.98	-0.81	-1.0	-0.73	-0.17	0.93	0.91	-0.71	-0.91	-0.6	-0.8	-0.91	0.58	-0.79		-0.82	-0.98	-0.8	-0.95	1.0	-0.98	-0.86
Capital Lease Obligations	0.67	-0.73	0.66	0.82	0.76	0.71	0.78	0.98	0.52	-0.66	-0.81	0.43	0.64	0.86	0.71	0.64	-0.44	0.81	-0.82		0.79	0.97	0.91	-0.8	0.76	0.99
Inventory	0.9	-0.85	0.92	0.94	0.95	0.89	0.98	0.69	0.05	-0.9	-0.94	0.65	0.9	0.57	0.88	0.9	-0.7	0.81	-0.98	0.79		0.8	0.94	-0.97	0.95	0.84
Other Current Assets	0.63	-0.66	0.68	0.84	0.73	0.76	0.76	0.95	0.45	-0.62	-0.83	0.43	0.61	0.74	0.76	0.61	-0.6	0.8	-0.8	0.97	0.8		0.9	-0.77	0.73	0.98
Other Stockholder Equity	0.81	-0.86	0.85	0.98	0.9	0.86	0.94	0.83	0.21	-0.83	-0.93	0.52	0.8	0.65	0.85	0.8	-0.58	0.9	-0.95	0.91	0.94	0.9		-0.94	0.9	0.94
Total Liab	-0.94	0.93	-0.85	-0.95	-0.99	-0.8	-1.0	-0.71	-0.15	0.95	0.89	-0.74	-0.93	-0.59	-0.8	-0.93	0.57	-0.76	1.0	-0.8	-0.97	-0.77	-0.94		-0.99	-0.83
Net Invested Capital	0.98	-0.88	0.79	0.9	1.0	0.82	0.98	0.66	0.07	-0.99	-0.81	0.79	0.98	0.6	0.82	0.98	-0.58	0.67	-0.98	0.76	0.95	0.73	0.9	-0.99		0.78
Property Plant And Equipment Gross	0.68	-0.77	0.74	0.88	0.78	0.75	0.82	0.96	0.46	-0.68	-0.88	0.43	0.65	0.79	0.75	0.65	-0.51	0.87	-0.86	0.99	0.84	0.98	0.94	-0.83	0.78

Click cells to compare fundamentals

Cognition Therapeutics Account Relationship Matchups

Cognition Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	7.1M	59.1M	50.4M	35.2M	30.2M	34.7M
Other Current Liab	1.2M	3.7M	2.6M	4.1M	7.9M	8.3M
Total Current Liabilities	3.3M	7.9M	7.8M	10.2M	11.1M	8.0M
Total Stockholder Equity	(68.2M)	51.3M	40.2M	24.5M	18.8M	19.7M
Property Plant And Equipment Net	211K	145K	1.0M	941K	679K	608.9K
Net Debt	7.7M	(54.7M)	(40.1M)	(28.7M)	(24.5M)	(25.7M)
Retained Earnings	(68.2M)	(94.0M)	(115.4M)	(141.2M)	(175.2M)	(166.4M)
Accounts Payable	2.0M	4.2M	3.2M	3.7M	2.0M	3.2M
Cash	5.2M	54.7M	41.6M	29.9M	25.0M	29.2M
Non Current Assets Total	211K	145K	2.8M	941K	679K	926.4K
Cash And Short Term Investments	5.2M	54.7M	41.6M	29.9M	25.0M	29.2M
Net Receivables	1.2M	2.3M	3.7M	1.3M	2.7M	2.0M
Liabilities And Stockholders Equity	7.1M	59.1M	50.4M	35.2M	30.2M	34.7M
Non Current Liabilities Total	72.1M	4.2M	2.4M	520K	342K	324.9K
Other Current Assets	567K	11K	2.4M	3.0M	1.9M	1.4M
Other Stockholder Equity	222K	86.3M	155.8M	165.8M	193.9M	110.4M
Total Liab	75.3M	7.9M	10.2M	10.7M	11.5M	10.9M
Net Invested Capital	(55.3M)	51.3M	40.9M	25.0M	19.0M	20.0M
Property Plant And Equipment Gross	988K	1.0M	2.0M	2.0M	1.8M	1.6M
Total Current Assets	6.9M	59.0M	47.6M	34.2M	29.6M	33.8M
Accumulated Other Comprehensive Income	(187K)	(198K)	(199K)	(195K)	(175.5K)	(184.3K)
Net Working Capital	3.7M	51.1M	39.9M	24.1M	18.4M	25.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cognition Historical Balance Sheet

Cognition Therapeutics Inventory

2.41 Million

About Cognition Balance Sheet Analysis

Cognition Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Cognition Therapeutics balance sheet Correlations

Cognition Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cognition Therapeutics balance sheet Accounts

Also Currently Popular

Additional Tools for Cognition Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Long Term Debt	+ 1.0	Other Liab
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Total Liab	- 1.0	Net Tangible Assets
Non Current Liabilities Total	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Total Assets
Net Invested Capital	- 0.99	Total Liab